Middle East AI In Oncology Market (2025 - 2033) Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware), By Cancer Type (Breast Cancer, Lung Cancer), By Application, By End-use, By Country, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Market Definitions
                        1.2.1. Component
                        1.2.2. Cancer Type Segment
                        1.2.3. Application Segment
                        1.2.4. End Use
                    1.3. Information analysis
                        1.3.1. Market formulation & data visualization
                    1.4. Data validation & publishing
                    1.5. Information Procurement
                        1.5.1. Primary Research
                    1.6. Information or Data Analysis
                    1.7. Market Formulation & Validation
                    1.8. Market Model
                    1.9. Total Market: CAGR Calculation
                    1.10. Objectives
                        1.10.1. Objective 1
                        1.10.2. Objective 2
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Snapshot
                    2.3. Competitive Insights Landscape
Chapter 3. Middle East AI in Oncology Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook.
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                        3.2.4. Market challenges analysis
                    3.3. Middle East AI in Oncology Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                            3.3.2.4. Environmental Landscape
                            3.3.2.5. Legal Landscape
                            3.3.2.6. Social Landscape
                    3.4. Health-tech Innovation Analysis
                    3.5. Case Studies
Chapter 4. Middle East AI in Oncology Market: Component Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Middle East AI in Oncology Market Component Movement Analysis
                    4.3. Middle East AI in Oncology Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
                    4.4. Hardware
                        4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    4.5. Software Solutions
                        4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    4.6. Services
                        4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Middle East AI in Oncology Market: Cancer Type Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Middle East AI in Oncology Market Cancer Type Movement Analysis
                    5.3. Middle East AI in Oncology Market Size & Trend Analysis, by Cancer Type, 2021 to 2033 (USD Million)
                    5.4. Breast Cancer
                        5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.5. Lung Cancer
                        5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.6. Prostate Cancer
                        5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.7. Colorectal Cancer
                        5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.8. Brain Tumor
                        5.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    5.9. Others
                        5.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Middle East AI in Oncology Market: Application Estimates & Trend Analysis
                    6.1. Segment Dashboard
                    6.2. Middle East AI in Oncology Market Application Movement Analysis
                    6.3. Middle East AI in Oncology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
                    6.4. Diagnostics
                        6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.5. Radiation therapy
                        6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.6. Research & Development
                        6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.7. Chemotherapy
                        6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    6.8. Immunotherapy
                        6.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Middle East AI in Oncology Market: End Use Estimates & Trend Analysis
                    7.1. Segment Dashboard
                    7.2. Middle East AI in Oncology Market End Use Movement Analysis
                    7.3. Middle East AI in Oncology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
                    7.4. Hospitals
                        7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    7.5. Surgical Centers & Medical Institutes
                        7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
                    7.6. Others
                        7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Middle East AI in Oncology Market: Regional Estimates & Trend Analysis
                    8.1. Regional Market Share Analysis, 2024 & 2033
                    8.2. Market Size & Forecasts Trend Analysis, 2021 to 2033
                    8.3. Middle East
                        8.3.1. Saudi Arabia
                            8.3.1.1. Key country dynamics
                            8.3.1.2. Regulatory framework
                            8.3.1.3. Competitive scenario
                            8.3.1.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
                        8.3.2. UAE
                            8.3.2.1. Key country dynamics
                            8.3.2.2. Regulatory framework
                            8.3.2.3. Competitive scenario
                            8.3.2.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
                        8.3.3. Kuwait
                            8.3.3.1. Key country dynamics
                            8.3.3.2. Regulatory framework
                            8.3.3.3. Competitive scenario
                            8.3.3.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
                        8.3.4. Qatar
                            8.3.4.1. Key country dynamics
                            8.3.4.2. Regulatory framework
                            8.3.4.3. Competitive scenario
                            8.3.4.4. Qatar market estimates and forecasts, 2021 - 2033 (USD Million)
                        8.3.5. Oman
                            8.3.5.1. Key country dynamics
                            8.3.5.2. Regulatory framework
                            8.3.5.3. Competitive scenario
                            8.3.5.4. Oman market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
                    9.1. Company/Competition Categorization
                    9.2. Strategy Mapping
                    9.3. Company Market Position Analysis, 2024
                    9.4. Company Profiles/Listing
                        9.4.1. Lunit Inc.
                            9.4.1.1. Company overview
                            9.4.1.2. Financial performance
                            9.4.1.3. Product benchmarking
                            9.4.1.4. Strategic initiatives
                        9.4.2. Siemens Healthineers AG
                            9.4.2.1. Company overview
                            9.4.2.2. Financial performance
                            9.4.2.3. Product benchmarking
                            9.4.2.4. Strategic initiatives
                        9.4.3. GE HealthCare
                            9.4.3.1. Company overview
                            9.4.3.2. Financial performance
                            9.4.3.3. Product benchmarking
                            9.4.3.4. Strategic initiatives
                        9.4.4. NVIDIA Corporation
                            9.4.4.1. Company overview
                            9.4.4.2. Financial performance
                            9.4.4.3. Product benchmarking
                            9.4.4.4. Strategic initiatives
                        9.4.5. Roche
                            9.4.5.1. Company overview
                            9.4.5.2. Financial performance
                            9.4.5.3. Product benchmarking
                            9.4.5.4. Strategic initiatives
                        9.4.6. Insilico Medicine
                            9.4.6.1. Company overview
                            9.4.6.2. Financial performance
                            9.4.6.3. Product benchmarking
                            9.4.6.4. Strategic initiatives
                        9.4.7. Oracle
                            9.4.7.1. Company overview
                            9.4.7.2. Financial performance
                            9.4.7.3. Product benchmarking
                            9.4.7.4. Strategic initiatives
                        9.4.8. Intel Corporation
                            9.4.8.1. Company overview
                            9.4.8.2. Financial performance
                            9.4.8.3. Product benchmarking
                            9.4.8.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Middle East AI in oncology market, by country, 2021 - 2033 (USD Million)
Table 3 Middle East AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 4 Middle East AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 5 Middle East AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 6 Middle East AI in oncology market, by end use, 2021 - 2033 (USD Million)
Table 7 Saudi Arabia AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 8 Saudi Arabia AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 9 Saudi Arabia AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 10 Saudi Arabia AI in oncology market, by end use, 2021 - 2033 (USD Million)
Table 11 UAE AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 12 UAE AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 13 UAE AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 14 UAE AI in oncology market, by end use, 2021 - 2033 (USD Million)
Table 15 Kuwait AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 16 Kuwait AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 17 Kuwait AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 18 Kuwait AI in oncology market, by end use, 2021 - 2033 (USD Million)
Table 19 Qatar AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 20 Qatar AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 21 Qatar AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 22 Qatar AI in oncology market, by end use, 2021 - 2033 (USD Million)
Table 23 Oman AI in oncology market, by component, 2021 - 2033 (USD Million)
Table 24 Oman AI in oncology market, by cancer type, 2021 - 2033 (USD Million)
Table 25 Oman AI in oncology market, by application, 2021 - 2033 (USD Million)
Table 26 Oman AI in oncology market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Market formulation & validation
Fig. 5 Middle East AI in oncology market: Market outlook
Fig. 6 Middle East AI in oncology market: Segment outlook
Fig. 7 Middle East AI in oncology market: Competitive landscape outlook
Fig. 8 Parent market outlook
Fig. 9 Middle East AI in oncology market driver impact
Fig. 10 Middle East AI in oncology market restraint impact
Fig. 11 Middle East AI in oncology market: Component type outlook and key takeaways
Fig. 12 Middle East AI in oncology market: Component type movement analysis
Fig. 13 Hardware market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 14 Software solutions market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 15 Services market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 16 Middle East AI in oncology market: Cancer Type outlook and key takeaways
Fig. 17 Middle East AI in oncology market: Cancer Type movement analysis
Fig. 18 Breast cancer market estimates and forecasts,2021 - 2033 (USD Million)
Fig. 19 Lung cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 20 Prostate cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 21 Colorectal cancer market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 22 Brain tumor market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 23 Other cancers market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 24 Middle East AI in oncology market: Application outlook and key takeaways
Fig. 25 Middle East AI in oncology market: Application movement analysis
Fig. 26 Diagnostics estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 27 Radiation therapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 28 Research & development market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 29 Chemotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 30 Immunotherapy market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 31 Middle East AI in oncology market: End use outlook and key takeaways
Fig. 32 Middle East AI in oncology market: End use movement analysis
Fig. 33 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 34 Surgical centers & medical institutes market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 35 Others market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 36 Middle East AI in oncology market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 37 Saudi Arabia key country dynamics
Fig. 38 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 39 UAE key country dynamics
Fig. 40 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 41 Kuwait key country dynamics
Fig. 42 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 43 Qatar key country dynamics
Fig. 44 Qatar market estimates and forecasts, 2021 - 2033 (USD Million)
Fig. 45 Oman key country dynamics
Fig. 46 Oman market estimates and forecasts, 2021 - 2033 (USD Million)